EU Agency Says Benefits of J&J Covid-19 Vaccine Outweigh Risks but Calls for Blood-Clot Warning

Johnson & Johnson’s Covid-19 vaccine has been put on hold in the U.S.


Szilard Koszticsak/Associated Press

The European Union Medicines Agency said a warning should be added to the product information of the

Johnson & Johnson

Covid-19 vaccine that unusual blood clots are a very rare possible side effect, but that the benefits of taking the shot outweigh the risks.

The agency said that healthcare professionals should be on the lookout for the combination of blood clots and low platelet levels.

Copyright ©2020 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8

Source link